Email Not Verified

Action Required

Please go to your profile settings and make sure your email is verified before applying for account verification.

Please refer to the documentation here.

Confirm Account Verification

Final Step

Please make sure you have filled in all the required details.

We need these details to verify your account. Once you click Yes, we will send an account activation request to our team.

Please refer to the documentation here.
Back to Top
Go Back
Journal Photo for Current Neuropharmacology
Peer reviewed only Open Access

Current Neuropharmacology (CN)

Publisher : Bentham Science Publishers B.V.
multidisciplinary
Claim Your Journal Get PRC Visit Website
e-ISSN 1875-6190
p-ISSN 1570-159X
Issue Frequency Monthly
Impact Factor 5.3
Est. Year 2003
DOI YES
Language English
APC YES
Email subscriptions@benthamscience.net

Journal Descriptions

Current Neuropharmacology aims to provide current, comprehensive/mini-reviews. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. Moreover, position papers and research articles/clinical trials of great novelty and scientific interest might occasionally be considered for publication, along with guest-edited issues in all areas of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Current Neuropharmacology (CN) is :-

  • International, Peer-Reviewed, Open Access, Refereed, multidisciplinary , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1570-159X, E-ISSN: 1875-6190, Established: 2003, Impact Factor: 5.3
  • Provides Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Publications of CN

Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role ...
Ashish Tiwari February, 2018
Alzheimer disease (AD) is now considered as a multifactorial neurodegenerative disorder and rapidly increasing to an alarming situation and causing higher death rate. One target one ligand h...